BCM
LVACW

Basso Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Basso Capital Management’s Portfolio LVACW Stock Details LVACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-98,820
Closed -$8K – 304
2022
Q3 		$8K Sell
98,820
-1,180
-1% -$207 ﹤0.01% 293
2022
Q2 		$11K Hold
100,000
– – ﹤0.01% 509
2022
Q1 		$35K Hold
100,000
– – ﹤0.01% 504
2021
Q4 		$57K Buy
+100,000
New +$51.3K 0.01% 426

Other funds holding LVACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Basso Capital Management's LVACW Position: Q4 2022 in Review

Basso Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q4 2022, closing a stake of 98,820 shares — an estimated $8K sold.

Basso Capital Management first reported a position in LVACW in Q4 2021 and held it in 4 quarters. The position peaked at $57K in Q4 2021. 33 funds tracked by Wall St. Rank hold LVACW as of Q4 2022.

  • Basso Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
  • Basso Capital Management sold 98,820 LAVA Medtech Acquisition Corp. Warrants shares in Q4 2022, an estimated $8K.
  • Basso Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 4 quarters.
  • Basso Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $57K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.